Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics
@article{Stoehr1984EffectOO, title={Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics}, author={Gary P. Stoehr and Patricia D. Kroboth and Randy P. Juhl and Donald B. Wender and J. Paul Phillips and Randall B. Smith}, journal={Clinical Pharmacology \& Therapeutics}, year={1984}, volume={36} }
The effects of low‐dose estrogen oral contraceptives (OC) on the elimination of the oxidized benzodiazepines triazolam (TRZ) and alprazolam (ALP) and the conjugated benzodiazepines temazepam (TMZ) and lorazepam (LOR) were studied in two parallel crossover studies of 20 women each. Women taking OC steroids containing low doses of estrogen and women matched for age, weight, and cigarette smoking received single oral doses of TRZ (0.5 mg) and TMZ (30 mg) or ALP (1 mg) and LOR (2 mg). Kinetics were…
96 Citations
Pharmacodynamic evaluation of the benzodiazepine–oral contraceptive interaction
- Medicine, PsychologyClinical pharmacology and therapeutics
- 1985
The data suggest that differences in benzodiazepine pharmacokinetics between OC users and control women do not account for observed differences in psychomotor impairment, and women taking OCs are more sensitive to the Psychomotor effects of single oral doses of Benzodiazepines.
DISPOSITION ral contraceptives containing ethinyl estradiol nd gestodene markedly increase plasma oncentrations and effects of tizanidine by nhibiting cytochrome P 450 1 A 2
- Medicine
- 2005
OCs containing ethinyl estradiol and gestodene increase, to a clinically significant extent, the plasma concentrations and effects of tizanidine, probably mainly by inhibiting its CYP1A2-mediated presystemic metabolism.
Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
- Medicine, BiologyBritish journal of clinical pharmacology
- 1990
The accelerated glucuronidation of phenprocoumon in OCS users suggests the need for careful monitoring of the anticoagulatory response in these subjects, especially when the OCS are withdrawn.
The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects.
- Medicine, ChemistryBritish journal of clinical pharmacology
- 2003
Oral contraceptives containing ethinyloestradiol but not those containing only LNG decrease CYP2C19 activity and neither of the OC preparations seemed to have an inhibitory effect on the formation of omeprazole sulphone by CYP3A4.
Alprazolam Pharmacokinetics in Women on Low‐Dose Oral Contraceptives
- Medicine, BiologyJournal of clinical pharmacology
- 1988
Alprazolam free fraction in plasma was slightly but significantly greater in the oral contraceptive group as opposed to the control group, however, comparison of free clearance between groups revealed no significant difference.
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1k-hydroxylation
- Medicine, Biology
- 2000
It is suggested that, at the doses used, ethinylestradiol and gestodene have a relatively small effect on CYP3A4 activity in vivo, and slightly increased the AUC of oral midazolam.
Lack of effect of oral contraceptive use on the pharmacokinetics of quinine.
- Medicine, BiologyBritish journal of clinical pharmacology
- 1991
The pharmacokinetics of quinine after a single 600 mg oral dose of quinine sulphate were studied in seven female subjects who used oral contraceptives and in seven age-matched female controls who did…
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.
- Biology, MedicineBritish journal of clinical pharmacology
- 2000
It is suggested that, at the doses used, ethinylestradiol and gestodene have a relatively small effect on CYP3A4 activity in vivo, and slightly increased the AUC of oral midazolam.
Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
- Medicine, BiologyBritish journal of clinical pharmacology
- 2004
Pharmacokinetic interactions of synthetic sexual steroids with saquinavir are not likely to account for the increased ADR to antiretroviral therapy seen in women.
Pharmacokinetics of oxaprozin in women receiving conjugated estrogen
- Biology, MedicineEuropean Journal of Clinical Pharmacology
- 2004
Oxaprozin clearance, accomplished by a combination of oxidation and conjugation, is unimpaired by coadministration of conjugatedEstrogen, and the kinetics of a single 1200 mg oral dose was studied in 22 healthy female volunteers.
References
SHOWING 1-10 OF 28 REFERENCES
Differential Effects of Oral Contraceptive Steroids on the Metabolism of Benzodiazepines
- Medicine, BiologyHepatology
- 1983
It is concluded that OCS exert a differential effect on the elimination of benzodiazepines, whereby oxidation of chlordiazepoxide is impaired while the glucuronidation of lorazepam and oxzepam is enhanced by OCS.
Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
- MedicinePharmacology
- 1984
The capacities for drug oxidation and conjugation appear to be controlled by different mechanisms, and clearance of antipyrine and acetaminophen across both studies was not statistically significantly correlated within individuals.
Impairment of antipyrine metabolism by low‐dose oral contraceptive steroids
- MedicineClinical pharmacology and therapeutics
- 1981
Even low‐dose estrogen containing OCS may impair clearance of other drugs, since volume of distribution and body weight are of the same order in both groups, prolongation of antipyrine t½β is the result of decreased total metabolic clearance.
Effects of oral contraceptive steroids on acetaminophen metabolism and elimination
- Medicine, BiologyClinical pharmacology and therapeutics
- 1983
The data suggest that the increased clearance of acetaminophen from plasma in women taking OC steroids results from increased glucuronidation of the drug, although the mechanism is not known.
Clinical Pharmacokinetics of Oxazepam and Lorazepam
- Medicine, BiologyClinical pharmacokinetics
- 1981
3-hydroxy benzodiazepine derivatives used as sedatives and anxiolytics and Oral and intramuscular lorazepam are rapidly absorbed, with systemic availability averaging 90 % or more.
Disposition of chlordiazepoxide: Sex differences and effects of oral contraceptives
- Medicine, BiologyClinical pharmacology and therapeutics
- 1979
There is considerable interspecies and interdrug variability in the effect of sex differences and oral contraceptive steroids on hepatic drug elimination and women on OC steroids had a lower plasma binding and a higher volume of distribution, but these differences were not statistically significant.
Increased Metabolic Clearance of Acetaminophen with Oral Contraceptive Use
- Medicine, BiologyObstetrics and gynecology
- 1982
Low-dose estrogen oral contraceptive steroid may stimulate the metabolism of a conjugatively metabolized drug such as acetaminophen, in contrast to contraceptive steroid impairment of the clearance of some oxidatively metabolizer drugs, with antipyrine being the prototype.
Impaired elimination of caffeine by oral contraceptive steroids.
- Medicine, BiologyThe Journal of laboratory and clinical medicine
- 1980
It is concluded that OCS impair the elimination of caffeine, and women on OCS had a significantly lower total plasma clearance and free clearance than women not taking OCS.
Triazolam disposition
- BiologyClinical pharmacology and therapeutics
- 1981
The results are consistent with the short duration of action of T‐14C, and nonconjugated α‐HT and 4‐HT were present in plasma but in insufficient amounts for kinetic analysis.
Pharmacokinetics of the hypnotic benzodiazepine, temazepam.
- Biology, MedicineBritish journal of clinical pharmacology
- 1979
To determine the absorption and elimination kinetics of temazepam from Normison® soft gelatin capsules, six healthy male volunteer subjects between 20 and 30 years of age and free of other medications for at least 1 week before the trial received 20 mg orally with a glass of water and on an empty stomach.